Evaluating Disparities in Precision Oncology

Launched by INDIANA UNIVERSITY · Oct 7, 2023

Keywords

ClinConnect Summary

This clinical trial, called "Evaluating Disparities in Precision Oncology," is focused on understanding how different factors, like genetics and social background, affect the treatment of metastatic or advanced cancer. Researchers are collecting important information from patients who are part of tumor boards at four cancer centers. These tumor boards help doctors decide on the best treatment options for patients based on their unique cancer profiles.

To participate in this study, patients need to be at least 18 years old and have been diagnosed with advanced or metastatic cancer. They also need to be planning to undergo a specific type of genetic testing as part of their regular cancer care. Participants will need to provide written consent, which means they agree to take part in the study. The trial is currently looking for patients who identify as either Black or White. Those who join can expect to share information about their health and background, which will help researchers learn more about how to improve cancer care for everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Ability to provide written informed consent and HIPAA authorization
• • 2. Patients must be ≥ 18 years old at the time of consent
• • 3. Patients planning to undergo molecular testing as part of their routine cancer care
• Exclusion Criteria:
• • N/A